Faron Pharmaceuticals Oy (LON:FARN – Get Free Report) passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 45.26 and traded as low as GBX 41. Faron Pharmaceuticals Oy shares last traded at GBX 43.99, with a volume of 38,071 shares changing hands.
Faron Pharmaceuticals Oy Trading Up 3.5%
The company’s 50 day moving average price is GBX 45.26 and its two-hundred day moving average price is GBX 119.13. The company has a debt-to-equity ratio of -133.35, a current ratio of 0.84 and a quick ratio of 1.09. The stock has a market capitalization of £87.75 million, a PE ratio of -1.99 and a beta of 1.18.
Faron Pharmaceuticals Oy Company Profile
Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development.
Recommended Stories
- Five stocks we like better than Faron Pharmaceuticals Oy
- YETI Rallies After Earnings Beat and Raised Outlook
- How the 3 Leading Quantum Firms Stack Up After Q1 Earnings
- Cisco’s Vertical Rally May Still Be in the Early Innings
- Amazon vs. Alibaba: One Is Clearly The Better Value Play right Now
Receive News & Ratings for Faron Pharmaceuticals Oy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Faron Pharmaceuticals Oy and related companies with MarketBeat.com's FREE daily email newsletter.
